πŸ‡ΈπŸ‡¬

Singapore for Biotech / Life Sciences

asiaTerritorialBIOTECH / LIFE SCIENCES
83
Overall
73
BIOTECH
Industry Rank
#1of 27
Key Strength
Tax
Tax Regime
Territorial
Verdict
Best For

Founders who want to minimise corporate tax - Singapore's tax environment scores 100/100, making it ideal for profitable businesses prioritising tax efficiency.

Not Ideal For

Fully remote teams without local presence - Singapore's remote infrastructure score (35/100) presents some limitations.

Bottom Line

Ranked #1 of 27 jurisdictions for Biotech / Life Sciences. Singapore's Biotech / Life Sciences score of 73/100 is close to its overall score of 83/100, indicating balanced performance across dimensions.

BIOTECH / LIFE SCIENCES-WEIGHTED DIMENSION PROFILE

Muted: default profile / Blue: industry-weighted

Strengths
Tax100

Strong tax environment for biotech / life sciences operators.

Ecosystem100

Strong ecosystem environment for biotech / life sciences operators.

Practical91

Strong practical environment for biotech / life sciences operators.

Watch Outs
Remote35

Lower remote score - verify current requirements carefully.

Visa75

Lower visa score - verify current requirements carefully.

Residency75

Lower residency score - verify current requirements carefully.

Key Metrics for Biotech / Life Sciences
17%
Corporate Tax
180
Active VCs
$4.2B
VC Deployed
Yes
Gov Grants
No
EU Funding
85
Talent Pool
Yes
IP Box Regime
1
Incorporation

Why Singapore Works for Biotech / Life Sciences

Corporate tax efficiency (100/100) is one of Singapore's strongest dimensions for Biotech / Life Sciences founders. Key features include a 17% statutory corporate tax rate, a territorial tax system that exempts foreign-sourced income, an IP box regime at 5% for qualifying intellectual property income, viable holding company structures for profit extraction. With 93 active tax treaties, cross-border payment withholding tax is manageable for internationally structured businesses.

Startup ecosystem quality (100/100) is a key reason Singapore ranks well for Biotech / Life Sciences. 25 unicorns have originated here, signalling institutional knowledge about building and scaling companies. Talent pool quality scores 85/100, and average senior developer salaries run $110K/year. Sector specializations relevant to Biotech / Life Sciences include: fintech, logistics, deeptech.

Operational ease (91/100) makes Singapore practical for Biotech / Life Sciences founders setting up from scratch. Banking difficulty for foreigners is rated easy. Company formation takes approximately 1 days at a cost of around $500, with annual compliance costs around $3K. Full foreign ownership is permitted - no local partner required. IP protection quality is rated strong, which matters for Biotech / Life Sciences businesses with proprietary technology or brand assets.

Watch Outs for Biotech / Life Sciences Founders in Singapore

Remote infrastructure (35/100): Singapore presents some limitations for fully remote teams. Connectivity, coworking density, or legal clarity for remote work may require additional planning for distributed Biotech / Life Sciences operations.

Setup Requirements for Biotech / Life Sciences in Singapore
  1. Entity type: 100% foreign-owned company permitted - no local partner required
  2. Banking: easy access for foreign founders. Common options include DBS, OCBC, UOB.
  3. Formation: approximately 1 days to incorporate, estimated cost $500 plus annual compliance of $3K
  4. Licensing: Regulator - HSA (Health Sciences Authority)
  5. Timeline: 42 days visa processing + 1 days formation = approximately 43 days to be fully operational
  6. Visa pathway: EntrePass (minimum investment $50K, 12-month initial permit)
Industry Key Facts
HSA (Health Sciences Authority)
Regulator
World-class R&D cluster
Biopolis
Efficient CIRB process
Phase I Trial
Specialized IP courts
IP Courts
Compare Singapore vs Top Alternatives for Biotech / Life Sciences
πŸ‡ΈπŸ‡¬Singapore
73
πŸ‡ͺπŸ‡ͺEstonia
68

Biotech / Life Sciences industry scores

πŸ‡ΈπŸ‡¬Singapore
73
πŸ‡ΉπŸ‡­Thailand
50

Biotech / Life Sciences industry scores

Top Biotech / Life Sciences Jurisdictions
Frequently Asked Questions
Is Singapore good for Biotech / Life Sciences in 2026?

Singapore ranks #1 of 27 jurisdictions for Biotech / Life Sciences on NomadSignal's scoring model, with an industry-weighted score of 73/100. The top strengths for Biotech / Life Sciences founders are corporate tax and startup ecosystem. Whether it is the right choice depends on your funding stage, personal tax situation, and whether you are relocating alone or with a family.

What is the corporate tax rate in Singapore?

Singapore applies a statutory corporate tax rate of 17%, with a territorial system that exempts foreign-sourced income from corporate tax, and an IP box regime at 5% for qualifying IP income. The jurisdiction has 93 active tax treaties. For Biotech / Life Sciences founders, corporate tax efficiency carries a 8% weight in the industry scoring model. Verify the current effective rate with a local advisor before making an incorporation decision.

Does Singapore have Biotech / Life Sciences-specific programs or incentives?

HSA (Health Sciences Authority) offers relatively fast approval timelines with a reference approval pathway linked to FDA/EMA. Biopolis is a world-class life sciences cluster. Strong IP protection with 20-year patent terms and effective courts. Singapore offers a startup or entrepreneur visa pathway for qualifying founders. NomadSignal evaluates Biotech / Life Sciences-specific factors including Regulatory Approval Pathway, Clinical Trial Environment, Patent Regime for Biologics as part of the industry score. Check the country's official government and innovation agency websites for current program details.

How does Singapore compare to other jurisdictions for Biotech / Life Sciences?

Singapore ranks #1 for Biotech / Life Sciences with 73/100. The #1 ranked jurisdiction is United Kingdom at 70/100. Singapore leads primarily on corporate tax. Use NomadSignal's comparison pages to evaluate Singapore head-to-head against specific alternatives.

Discussion (0)

A community of sovereign individuals - founders, families, and remote operators. Share what you know, ask what you don't.

No comments yet - be the first to share what you know about this page.

Data as of March 2026. Not legal, tax, or immigration advice.